Scholtz & Company’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,800
Closed -$1.69M 50
2022
Q3
$1.69M Sell
33,800
-47,880
-59% -$2.13M 1.21% 24
2022
Q2
$3.48M Sell
81,680
-1,080
-1% -$51.4K 2.14% 17
2022
Q1
$4.45M Sell
82,760
-530
-0.6% -$30.9K 1.76% 21
2021
Q4
$5.99M Buy
83,290
+2,160
+3% +$135K 1.94% 21
2021
Q3
$4.62M Buy
+81,130
New +$4.94M 1.63% 24

Other funds holding LRCX

Scholtz & Company's LRCX Position: Q4 2022 in Review

Scholtz & Company sold out of Lam Research (LRCX) in Q4 2022, closing a stake of 33,800 shares — an estimated $1.69M sold.

Scholtz & Company first reported a position in LRCX in Q3 2021 and held it in 5 quarters. The position peaked at $5.99M in Q4 2021. 1,346 funds tracked by Wall St. Rank hold LRCX as of Q4 2022.

  • Scholtz & Company reported no remaining Lam Research position as of Q4 2022 after selling out during the quarter.
  • Scholtz & Company sold 33,800 Lam Research shares in Q4 2022, an estimated $1.69M.
  • Scholtz & Company first reported a position in Lam Research in Q3 2021 and held it in 5 quarters.
  • Scholtz & Company's Lam Research position peaked at $5.99M in Q4 2021.
  • 1,346 funds tracked by Wall St. Rank held Lam Research as of Q4 2022.

Based on Scholtz & Company's 13F filing for Q4 2022, filed 14 Feb 2023.